SINTX TECHNOLOGIES (SINT)
(Real Time Quote from BATS)
$2.53 USD
-0.16 (-5.95%)
Updated Nov 12, 2024 02:53 PM ET
NA Value
NA Growth NA Momentum NA VGMSINTX TECHNOLOGIES, INC. (SINT) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$70.00 | $70.00 | $70.00 | 2,502.23% |
Price Target
Only one analyst offered a short-term price target of $70.00 for SINTX TECHNOLOGIES, INC. This represents an increase of 2% from the last closing price of $2.69.
Analyst Price Targets (1 )
Broker Rating
SINTX TECHNOLOGIES, INC. currently has an average brokerage recommendation (ABR) of 2.50 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by two brokerage firms. The current ABR compares to an ABR of 2.50 a month ago based on two recommendations.
Of the two recommendations deriving the current ABR, one is Buy, representing 50% of all recommendations. A month ago, Buy represented 50%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 |
Buy | 1 | 1 | 1 | 0 | 0 |
Hold | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.50 | 2.50 | 2.50 | 3.00 | 3.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
6/21/2024 | Maxim Group | Tate Sullivan | Hold | Hold |
5/31/2024 | Ascendiant Capital Markets | Edward M Woo | Not Available | Moderate Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.50 |
ABR (Last week) | 2.50 |
# of Recs in ABR | 2 |
Average Target Price | $70.00 |
LT Growth Rate | NA |
Industry | Medical - Instruments |
Industry Rank by ABR | 66 of 252 |
Current Quarter EPS Est: | NA |